Article Versions Notes

Wiciński M, Fajkiel-Madajczyk A, Kurant Z, Gryczka K, Kurant D, Szambelan M, Malinowski B, Falkowski M, Zabrzyński J, Słupski M. The Use of Cannabidiol in Metabolic Syndrome—An Opportunity to Improve the Patient’s Health or Much Ado about Nothing? Journal of Clinical Medicine. 2023; 12(14):4620. https://doi.org/10.3390/jcm12144620

Wiciński, Michał, Anna Fajkiel-Madajczyk, Zuzanna Kurant, Karol Gryczka, Dominik Kurant, Monika Szambelan, Bartosz Malinowski, Michal Falkowski, Jan Zabrzyński, and Maciej Słupski. 2023. "The Use of Cannabidiol in Metabolic Syndrome—An Opportunity to Improve the Patient’s Health or Much Ado about Nothing?" Journal of Clinical Medicine 12, no. 14: 4620. https://doi.org/10.3390/jcm12144620

Wiciński, M., Fajkiel-Madajczyk, A., Kurant, Z., Gryczka, K., Kurant, D., Szambelan, M., Malinowski, B., Falkowski, M., Zabrzyński, J., & Słupski, M. (2023). The Use of Cannabidiol in Metabolic Syndrome—An Opportunity to Improve the Patient’s Health or Much Ado about Nothing? Journal of Clinical Medicine, 12(14), 4620. https://doi.org/10.3390/jcm12144620